Victory Capital Management Inc Xeris Biopharma Holdings, Inc. Transaction History
Victory Capital Management Inc
- $99 Billion
- Q3 2024
A detailed history of Victory Capital Management Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 17,518 shares of XERS stock, worth $61,663. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,518
Previous 17,884
2.05%
Holding current value
$61,663
Previous $40,000
22.5%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding XERS
# of Institutions
144Shares Held
60.1MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$36.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$27.3 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$18 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$12.3 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $479M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...